Scientific protein specialists Wobble Genomics has raised £1.2m in a funding round led by Eos Advisory.
The spin-out from University of Edinburgh’s Roslin Institute was launched by chief executive Richard Kuo in April 2021.
It specialises in the study of RiboNucleic Acid (RNA) sequencing, a messenger between DNA and protein synthesis, and has developed a range of hardware and software tools that give scientists and clinicians a more detailed picture of underlying biology.
Wobble is already conducting trials with some of the world’s largest RNA sequencing organisations, and the investment is supporting the expansion of staff, strengthening its intellectual property.
St Andrews-based Eos leads the investment round, alongside the University of Edinburgh’s in-house venture investment fund Old College Capital.
This investment will form part of a £2.15m seed-round, including a deeptech venture capital firm and a small number of private investors.
Read more HERE.